David Torgerson
David Torgerson
York Trials Unit, Department of Health Sciences, University of York
Verified email at york.ac.uk
Title
Cited by
Cited by
Year
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women
JA Kanis, A Odén, O Johnell, H Johansson, C De Laet, J Brown, ...
Osteoporosis international 18 (8), 1033-1046, 2007
11892007
Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo …
RECORD Trial Group
The Lancet 365 (9471), 1621-1628, 2005
11092005
Guidelines for diagnosis and management of osteoporosis
JA Kanis, P Delmas, P Burckhardt, C Cooper, D Torgerson
Osteoporosis International 7 (4), 390-406, 1997
9701997
Understanding controlled trials: What are pragmatic trials?
M Roland, DJ Torgerson
Bmj 316 (7127), 285, 1998
7851998
Hormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomized trials
DJ Torgerson, SEM Bell-Syer
Jama 285 (22), 2891-2897, 2001
7142001
Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care
J Porthouse, S Cockayne, C King, L Saxon, E Steele, T Aspray, ...
Bmj 330 (7498), 1003, 2005
6622005
United Kingdom back pain exercise and manipulation (UK BEAM) randomised trial: effectiveness of physical treatments for back pain in primary care
UK Beam Trial Team
Bmj 329 (7479), 1377, 2004
5802004
Randomised controlled trial of exercise for low back pain: clinical outcomes, costs, and preferences
JK Moffett, D Torgerson, S Bell-Syer, D Jackson, H Llewlyn-Phillips, ...
Bmj 319 (7205), 279-283, 1999
4971999
Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials
S Cockayne, J Adamson, S Lanham-New, MJ Shearer, S Gilbody, ...
Archives of internal medicine 166 (12), 1256-1261, 2006
4852006
A UK Consensus Group on management of glucocorticoid‐induced osteoporosis: an update
R Eastell, DM Reid, J Compston, C Cooper, I Fogelman, RM Francis, ...
Journal of internal medicine 244 (4), 271-292, 1998
4491998
Contamination in trials: is cluster randomisation the answer?
DJ Torgerson
Bmj 322 (7282), 355-357, 2001
4422001
Should we pay the patient? Review of financial incentives to enhance patient compliance
A Giuffrida, DJ Torgerson
Bmj 315 (7110), 703-707, 1997
4391997
Designing randomised trials in health, education and the social sciences: an introduction
D Torgerson
Springer, 2008
4262008
Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe
DIPART (Vitamin D Individual Patient Analysis of Randomized Trials) Group
The BMJ 340, 2010
3882010
Rethinking pragmatic randomised controlled trials: introducing the “cohort multiple randomised controlled trial” design
C Relton, D Torgerson, A O’Cathain, J Nicholl
Bmj 340, 2010
3852010
Understanding controlled trials. What is a patient preference trial?
DJ Torgerson, B Sibbald
BMJ: British Medical Journal 316 (7128), 360, 1998
385*1998
General anaesthesia versus local anaesthesia for carotid surgery (GALA): a multicentre, randomised controlled trial
GTC Group
The Lancet 372 (9656), 2132-2142, 2008
3742008
Systematic review of stepped wedge cluster randomized trials shows that design is particularly used to evaluate interventions during routine implementation
ND Mdege, MS Man, CA Taylor, DJ Torgerson
Journal of clinical epidemiology 64 (9), 936-948, 2011
3562011
Cost of illness studies
S Byford, DJ Torgerson, J Raftery
Bmj 320 (7245), 1335, 2000
3452000
Evidence for risk of bias in cluster randomised trials: review of recent trials published in three general medical journals
S Puffer, D Torgerson, J Watson
Bmj 327 (7418), 785-789, 2003
3402003
The system can't perform the operation now. Try again later.
Articles 1–20